Literature DB >> 3084793

Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin.

C Brown, J Pedersen, J R Underwood, I Gust, B H Toh.   

Abstract

Using ELISA and immunoblotting, autoantibodies to vimentin were sought in sera from 10 patients with acute hepatitis A, 10 with acute hepatitis B, 13 with acute non-A, non-B hepatitis, 16 with autoimmune chronic active hepatitis, 17 with cytomegalovirus infection and 40 from healthy persons. The ELISA results were expressed as a percentage of the value obtained with a monoclonal antibody to vimentin. The results (mean and SD) for acute hepatitis A (51.2 +/- 21.7%), acute hepatitis B (44.5 +/- 28.2%) and acute hepatitis non-A, non-B (43.0 +/- 16.4%) were significantly (p less than 0.01) higher than those for autoimmune chronic active hepatitis (20.5 +/- 7.7%), cytomegalovirus infection (25.9 +/- 12.2%) and healthy controls (16.8 +/- 9.3%). Immunoblotting showed that sera from patients with acute viral hepatitis reacted with 57 kd vimentin in triton-cytoskeletal extracts of fibroblasts. These results show that autoantibodies to vimentin are present in sera from patients with acute hepatitis A, B and non-A, non-B. Antivimentin autoantibodies may be useful in the diagnosis of acute non-A, non-B hepatitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084793

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  8 in total

1.  Identification, using sera from exposed animals, of putative viral antigens in livers of primates with callitrichid hepatitis.

Authors:  C B Stephensen; R J Montali; E C Ramsay; K V Holmes
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  Serum non-organ specific autoantibodies in human immunodeficiency virus 1 infection.

Authors:  F Cassani; L Baffoni; E Raise; L Selleri; M Monti; L Bonazzi; F M Gritti; F B Bianchi
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

3.  Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study.

Authors:  B Dasgupta; O Duke; V Kyle; D G Macfarlane; B L Hazleman; G S Panayi
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

4.  Human cytomegalovirus attenuates interleukin-1beta and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-kappaB activation.

Authors:  Michael A Jarvis; Jamie A Borton; Amy M Keech; John Wong; William J Britt; Bruce E Magun; Jay A Nelson
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens.

Authors:  Stephanie C Joachim; Jan Reichelt; Simone Berneiser; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-12       Impact factor: 3.117

6.  Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis.

Authors:  Andrew J Kinloch; Matthew D Cascino; Jian Dai; Rene S Bermea; Kichul Ko; Margaret Vesselits; Leonard L Dragone; Nirit Mor Vaknin; Maureen Legendre; David M Markovitz; Michael K Okoreeh; Michael J Townsend; Marcus R Clark
Journal:  Lupus       Date:  2020-03-26       Impact factor: 2.911

Review 7.  Diagnostic autoantibodies for autoimmune liver diseases.

Authors:  Ban-Hock Toh
Journal:  Clin Transl Immunology       Date:  2017-05-05

8.  Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin.

Authors:  Erik R Vossenaar; Normand Després; Elvy Lapointe; Annemarie van der Heijden; Maximillian Lora; Tatsuo Senshu; Walther J van Venrooij; Henri A Ménard
Journal:  Arthritis Res Ther       Date:  2004-02-05       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.